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A B S T R A C T
There is growing support that cerebrovascular reactivity (CVR) in response to a vasodilatory challenge, also
deﬁned as the cerebrovascular reserve, is reduced in Alzheimer's disease dementia. However, this is less clear in
patients with mild cognitive impairment (MCI). The current standard analysis may not reﬂect subtle
abnormalities in CVR. In this study, we aimed to investigate vasodilatory-induced changes in the topology of
the cerebral blood ﬂow correlation (CBFcorr) network to study possible network-related CVR abnormalities in
MCI. For this purpose, four CBFcorr networks were constructed: two using CBF SPECT data at baseline and under
the vasodilatory challenge of acetazolamide (ACZ), obtained from a group of 26 MCI patients; and two
equivalent networks from a group of 26 matched cognitively normal controls. The mean strength of association
(SA) and clustering coeﬃcient (C) were used to evaluate ACZ-induced changes on the topology of CBFcorr
networks. We found that cognitively normal adults and MCI patients show diﬀerent patterns of C and SA
changes. The observed diﬀerences included the medial prefrontal cortices and inferior parietal lobe, which
represent areas involved in MCI's cognitive dysfunction. In contrast, no substantial diﬀerences were detected by
standard CVR analysis. These results suggest that graph theoretical analysis of ACZ-induced changes in the
topology of the CBFcorr networks allows the identiﬁcation of subtle network-related CVR alterations in MCI,
which couldn't be detected by the standard approach.
1. Introduction
There is increasing evidence that patients with Alzheimer's disease
(AD) dementia have decreased cerebrovascular reactivity (CVR) in
response to a vasodilatory challenge, also deﬁned as the cerebrovas-
cular reserve (Glodzik et al., 2013, for a review). However, this is less
clear in patients during the prodromal mild cognitive impairment (MCI)
stage of AD. Some studies show a decrease (Richiardi et al., 2014;
Glodzik et al., 2011; Cantin et al., 2011; Zavoreo et al., 2010), while
others do not (Shim et al., 2015; Fromm et al., 2013; Anzola et al.,
2011). This issue is becoming important in AD research because it could
have implications for early diagnosis and treatment of AD. Early CVR
abnormalities, especially at the microvascular level, aﬀect the neuro-
vascular coupling and consequently the neural activation (Pillai and
Mikulis, 2015), which in turn alters the brain's functional integrity
(Iadecola, 2004).
MCI due to AD is the transition from normal cognition to dementia
(Albert et al., 2011). Accordingly, CVR abnormalities would be subtle
or borderline which may partly explain ambiguous ﬁndings, particu-
larly in MCI patients with a low vascular burden. Furthermore,
considering the complexity of the cerebral microvasculature network
the standard analysis of CVR might not reﬂect subtle network-related
alterations since it relies on the analysis of individual regions (or the
whole brain) rather than on the interaction between them.
Recently, graph theoretical analysis of large-scale structural MRI
(sMRI) correlation networks has shown its potential to reveal subtle
network-related pathological processes in MCI (Tijms et al., 2013; He
et al., 2009a, for reviews). We previously demonstrated that the
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cerebral blood ﬂow correlation (CBFcorr) network, based on CBF SPECT
data, shows a non-random topological organization (Melie-García et al.,
2013). The same topological organization had been previously observed
in sMRI correlation (Alexander-Bloch et al., 2013, for a review) and
ﬁber tractography networks (Iturria-Medina et al., 2008). Therefore, we
speculate that graph theoretical analysis can also be applied to CBF
SPECT data to detect possible subtle network-related CVR abnormal-
ities in MCI.
Here, we constructed four CBFcorr networks: two using CBF SPECT
data at baseline and under the vasodilatory challenge of acetazolamide
(ACZ), obtained from a group of relatively young MCI patients with
limited vascular risk factors; and two equivalent networks using a group
of matched cognitive normal controls. ACZ is a reproducible, simple,
and a safe vasodilatory stimulus (Vagal et al., 2009, for a review).
Graph metrics based on the concepts of the mean strength of
association (SA) (Bullmore and Bassett, 2011) and clustering coeﬃcient
(C) (Watts and Strogatz, 1998) were used to evaluate ACZ-induced
changes on the topology of the CBFcorr networks. The SA for a particular
brain region (node) measures the correlation's mean (co-variation's
mean) with the rest of the network; while Cmeasures local connectivity
(i.e. how well neighbors of a node are connected).
Hence, using graph theoretical analysis, our aim was to investigate
ACZ-induced changes in the topology of the CBFcorr network to study
possible network-related CVR abnormalities in MCI. We also investi-
gated CVR by the standard approach in the same groups of subjects for
comparing with graph theoretical analysis ﬁndings.
2. Methods
2.1. Subjects
Twenty-six MCI patients and twenty-six clinically healthy control
volunteers were studied, selected from one hundred subjects recruited
over a two-year period and a one-year follow-up and based on the
inclusion and exclusion criteria detailed below. The Ethics Committee
of the Center for Neurological Restoration of Havana, Cuba, approved
the study. All participating subjects gave written informed consent
according to the Helsinki Declaration. Table 1 summarizes sociodemo-
graphic and clinical characteristics of the MCI and control groups.
All subjects were screened for a complete medical history, routine
blood tests, cranial MRI, neuropsychological testing and neurological/
psychiatric examinations. Subjects were clinically diagnosed as MCI
using the criteria based on the Clinical Dementia Rating Scale (CDR)
(Morris, 1993). According to these criteria, subjects were classiﬁed as
MCI with CDR = 0.5; while normal cognitive subjects with CDR = 0.
All of MCI subjects maintained independence in their daily living. In
addition to the Mini-Mental State Examination (MMSE), speciﬁc
mnemonic and non-mnemonic cognitive tests were also performed for
all subjects to further characterize cognitive function (Supplementary
Table S1).
The inclusion criteria were: 1) MCI patients with memory com-
plaints as the main cognitive symptom, which worsened over a period
of one year; 2) subjects (patients and controls) with limited (and
treated) vascular risk factors, based upon clinical examination, blood
tests and magnetic resonance angiography (MRA) ﬁndings; 3) subjects
without signiﬁcant depression, according to the Hamilton Depression
Scale (score < 8) (Hamilton, 1960); 4) no prior or current treatment
with anti-acetylcholinesterase agents; and 5) right-handedness.
The exclusion criteria were: 1) signiﬁcant medical problems (i.e.
serious cardiac disease, poorly controlled diabetes or hypertension;
severe inﬂammatory, thyroid, renal, hepatic or other chronic diseases);
2) cerebrovascular disorders (i.e. transient ischemic attack or cerebral
infarction), moderate and severe carotid stenosis by MRA ﬁndings,
large white matter changes on MRI (based on T2 and FLAIR sequences),
hydrocephalus or intracranial mass; 3) history of traumatic brain
injury, migraine or another neurological disease; and 4) psychiatric
disorder, substance abuse or dependence.
2.2. CBF SPECT imaging under the acetazolamide challenge
CBF SPECT imaging was carried out by a double-head rectangular
gamma camera (Sopha Medical Vision, France) equipped with ultra-
high-resolution fan beam collimators. More about the acquisition and
reconstruction parameters, including corrections for attenuation and
partial volume eﬀect (PVE) due to atrophy, are described in our
preceding article (Melie-García et al., 2013). A two-day protocol was
used for CBF SPECT imaging at baseline (basal SPECT) and under the
ACZ challenge (ACZ SPECT).
Absolute measurement is necessary to quantify (optimally) the CBF
response to the vasodilatory stimulus (Boles Ponto et al., 2004).
Therefore, global CBF at basal condition (gCBFBasal) and under ACZ
(gCBFACZ) was determined in absolute units (mL/min/100 g) by
spectral analysis of non-invasive radionuclide angiographies
(Takasawa et al., 2002). The radionuclide angiography was performed
before SPECT acquisition, for both basal and ACZ conditions. Brieﬂy, a
radionuclide angiography of the head and chest was performed after
injection of 555 MBq of technetium-99-ethyl cysteinate dimer (ECD)
into the antecubital vein of the right arm under resting condition
(supine, eyes open, dimly lit quiet room) to estimate gCBFBasal. The
same procedure was repeated to estimate gCBFACZ but 20 min after
slow intravenous injection of 1 g of ACZ. Heart rate and arterial
pressure were measured at the time of the two injections of the tracer
(basal and ACZ).
Basal and ACZ SPECT images were then converted to basal and ACZ
quantitative CBF images using gCBFBasal and gCBFACZ, respectively, by
application of Lassen's linearization algorithm (Lassen et al., 1988). For
subsequent voxelwise statistical analysis, basal and ACZ quantitative
CBF images were normalized to the Montreal Neurological Institute
(MNI) space. The image normalization was performed by applying
DARTEL parameters (based on a fast diﬀeomorphic algorithm) obtained
from MRI preprocessing (see the next subsection). Normalized images
were then smoothed using a 14 mm-kernel to optimize sensitivity (Van
Laere et al., 2002).
2.3. Volumetric MRI
Volumetric high-resolution MRI was also performed to characterize
the MCI group regarding regional brain atrophy. Regional atrophy,
particularly hippocampal, is a biomarker of neuronal injury of MCI due
to AD (Albert et al., 2011; Sánchez-Catasús et al., 2017). Volumetric
MRI also had two other functions: to correct for PVE in CBF SPECT
images and to estimate spatial transformations that were used to
normalize images to MNI space, as described above.
MRI acquisition was performed using a 1.5 Tesla Symphony scanner
(Siemens, Erlangen, Germany). The acquisition protocol for volumetric
MRI is described in details in our previous study (Melie-García et al.,
Table 1
Sociodemographic and clinical features of control and MCI groups.
Control (N= 26) MCI (N= 26) p-value
Age (years) 60.9 ± 7.3 64.7 ± 6.9 0.06a
Gender (female/male) 13/13 14/12 0.78b
Education (years) 13.6 ± 3.9 11.8 ± 4.6 0.13a
MMSE 29.3 ± 1.1 26.9 ± 1.24 10−6a
Hypertension 27% 35% 0.55b
Hyperlipidemia 19% 23% 0.73b
Diabetes 15% 15% 1b
Smoking 27% 19% 0.51b
Data shown as mean ± SD or percent of subjects.
a Student t-tests for independent samples.
b Chi-square test.
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2013). The preprocessing steps were as follows: images were segmented
into GM and WM; imported into the DARTEL toolbox and normalized to
MNI space to generate warped and smoothed (12 mm-kernel) Jacobian
modulated GM and WM images. GM/WM modulated images represent
GM/WM volume images (GMV/WMV images). Global tissue volumes
were estimated in the native space using the Voxel-Based Morphometry
toolbox (VBM8: http://dbm.neuro.uni-jena.de/vbm8/).
For every subject, neurological/psychiatric/neuropsychological ex-
aminations, as well as SPECT and MRI, were carried out within a
maximum interval of one month.
2.4. Construction of the CBF correlation (CBFcorr) network
For each group of subjects (MCI and control) in each condition
(baseline and ACZ challenge), a CBFcorr network was constructed as a
CBF correlation matrix (Melie-García et al., 2013). In short, 90 ROIs
were deﬁned using the AAL atlas (Tzourio-Mazoyer et al., 2002) and
Pearson's correlation coeﬃcients were calculated (across subjects)
between all possible pairs of ROIs. Hence, the interregional correlation
matrix (90 × 90 ROIs) was obtained gathering together all correlation
coeﬃcients. Self-correlations were excluded, implying a diagonal of
zeros in the symmetric matrix. Prior to the correlation analysis, a linear
regression was performed at every ROI to remove the eﬀects of age,
gender, age–gender interaction, and global CBF values. For computing
the CBF correlation matrix, the correlation was carried out between the
residuals of this regression instead of the raw regional CBF values.
Fig. 1 shows CBF correlation matrices for each group in each condition.
For within-conditions and within-groups network metrics compar-
isons (see Sub-section 2.6.2), we obtained 1000 bootstrap samples (with
replacement) of each CBF correlation matrix. Paired bootstrap samples
were used for baseline and the ACZ challenge in each group.
2.5. Network metrics
In the following, we deﬁne SA (the mean strength of association)
(Bullmore and Bassett, 2011) and C (the clustering coeﬃcient) (Watts
and Strogatz, 1998) to study ACZ-induced changes in the CBF correla-
tion networks.
The SA for a particular brain region or node i, SAnodal (i), is deﬁned
as the mean of the absolute value of Pearson's correlation coeﬃcients
(Corrij) of node i with the rest N-1 nodes in the network. Formally,
SAnodal (i) is calculated as:
∑SA i N Corr( ) =
1
− 1nodal j
j i
N
ij
=1
≠
where N is the number of nodes (ROIs).
In simple terms, SAnodal measures the correlation's mean (co-
variation's mean) of a node with the rest of the network. SA is also
deﬁned at the network level (SAglobal) as the average of SAnodal:
Fig. 1. CBF correlation matrices (CBF correlation networks) constructed using CBF SPECT data at basal and under the acetazolamide (ACZ) challenge for MCI and cognitively normal
controls. The color bar indicates the value of the correlation coeﬃcient coming from the CBF co-variations among 90 anatomical brain regions (AAL atlas). For the sake of clarity brain
regions of the right (R) and left (L) hemispheres were separated.
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∑SA N SA i=
1 ( )global
i
N
nodal
=1
On the other hand, C is a measure of the tendency to cluster nodes
into strictly connected neighborhoods (a measure of network segrega-
tion; i.e. local connectivity). Nodes are considered neighbors when a
connection between them exists, which is not limited to a physical
neighborhood concept. Cnodal (i), for a binary and undirected graph G, is
the number of existing connections between the neighbors of node i
divided by all neighbor's possible connections. Formally, Cnodal (i) is
calculated as:
∑C i N
t
k k
( ) = 1 2
( − 1)nodal i G
i
i i∈
where ti is the number of triangles around node i (see below); and ki is
the degree of node i (number of links connected to node i); (for ki < 2,
Cnodal (i) = 0).
∑t a a a= 12i j h G ij ih jh, ∈
where aij is the connection status between i and j: aij = 1 when link (i, j)
exists (when i and j are neighbors); aij = 0 otherwise (aii = 0 for all i).
In simple terms, Cnodal measures how well neighbors of a node are
connected. C is also deﬁned at the network level (Cglobal) as the average
of Cnodal:
∑C N C i=
1 ( )global
i
N
nodal
=1
For each CBF correlation matrix, SAnodal and SAglobal were calculated
over the bootstrap samples. Since we used C deﬁned for a binary
(undirected) graph, Cnodal and Cglobal were calculated over bootstrap
samples of thresholded binary adjacency matrices. Rather than restrict-
ing the analysis to a binary graph obtained by applying a single
threshold value, Cnodal and Cglobal were calculated over a range of
thresholds or ‘sparsity degree’ values. A sparsity degree of 0.9 means
that 90% of the correlation matrix is discarded; consequently, only the
highest 10% of the values is taken into account. Sparsity degrees
ranging from 0.5 to 0.9 (in steps of 0.02) were used, yielding a set of 21
values. This procedure normalizes the networks to have the same
number of nodes and edges, enabling the examination of Cnodal and
Cglobal. The range of sparsity degree was chosen to allow for these
network properties to be estimated and the number of spurious edges in
each network minimized as indicated in previous studies (Achard and
Bullmore, 2007; He et al., 2007; Sanabria-Diaz et al., 2013).
Before calculating Cnodal (as described above), the largest connected
component (see Achard et al., 2006) of all bootstrap samples of CBF
correlation matrices was computed. The minimum sparsity degree for
the largest connected component (equal to the number of AAL nodes)
was used as the upper limit of the sparsity degree range. This step
guarantees that all Cnodal values come from fully connected CBFcorr
networks. Then, the Cnodal mean curve (across the range of sparsity
degree) was assessed over the bootstrap samples for every node and
used as the Cnodal descriptor.
On the other hand, the descriptor used for Cglobal was the area under
the curve (AUC) extracted from thresholding across the range of
sparsity degree over bootstrap samples for each group and condition.
Since the topology of the Cglobal curve is monotonic with the sparsity
degree, the AUC is a suitable descriptor for characterizing its global
performance. This descriptor was also adopted in previous studies
(Sanabria-Diaz et al., 2013; Wu et al., 2012; He et al., 2009b).
Construction of CBFcorr networks and computation of network
metrics was performed using the MorphoConnect toolbox (Melie-
García et al., 2010) and subroutines of the Brain Connectivity toolbox
(https://sites.google.com/site/bctnet/).
2.6. Statistical analysis
2.6.1. Changes in standard metrics
The data at the voxel level was analyzed by a 2 (group: Control and
MCI) × 2 (condition: basal and ACZ) full factorial design as implemen-
ted in the SPM8 toolbox. Age and gender were modeled as nuisance
covariates. The global eﬀect was also controlled using proportional
scaling.
We examined simple main eﬀects of condition (positive and
negative) in each group by t-contrasts for dependent samples; and
simple main eﬀects of group (positive and negative) in each condition
by t-contrasts for independent samples. We also studied the interaction
of group and condition (positive and negative).
A similar treatment (2 × 2 design) was also performed for global
CBF values, controlling for age and gender.
As a supplementary morphometric analysis, diﬀerences at the voxel
level between groups for GMV and WMV images were tested to evaluate
regional brain atrophy in the MCI group. Comparisons were performed
using the Student t-tests for independent samples through the SPM8
toolbox. The GMV and WMV images were masked using an absolute
threshold of 0.25 to avoid as much as possible contamination by
misclassiﬁed voxels. Age, gender, and total intracranial volume were
controlled.
In all SPM analyses, the statistical threshold of p = 0.01 (peak level)
was used. The extent threshold used was determined by the cluster of
voxels signiﬁcant at p = 0.05 (cluster level), corrected for multiple
comparisons (family-wise error method - FWE) and after correction of
non-isotropic smoothness. Anatomical regions were determined by
comparing voxel and cluster location with the AAL atlas (Tzourio-
Mazoyer et al., 2002). The most signiﬁcant voxels were reported in MNI
coordinates.
2.6.2. Changes in network metrics
Similar to the standard analysis, C and SA (global and nodal) were
analyzed by a 2 × 2 design. To examine simple main eﬀects of the
condition in each group for each network metric (or simple main eﬀects
of the group in each condition), we computed the diﬀerence between
the two conditions (or between the two groups) for the corresponding
bootstrap samples. Then, we constructed the bootstrap distribution of
the diﬀerence and computed the 95% BC (bias-corrected) bootstrap
conﬁdence interval (CI). A signiﬁcant diﬀerence between conditions (or
between groups) was considered when the CI did not contain the zero.
For Cnodal and SAnodal, we also corrected for multiple comparisons by
Bonferroni adjustment.
Likewise, we studied the interaction of group and condition (global
and nodal) by comparing simple main eﬀects of condition between
groups following the same procedure as described in the previous
paragraph. For instance, the diﬀerences between conditions in control
and MCI groups were subtracted and the 95% BC bootstrap CI was
calculated for the subtraction. As before, if CI did not contain the zero,
the interaction eﬀect was considered statistically signiﬁcant. Due to the
exploratory nature of this study, we also examined the interaction for
uncorrected values at the nodal level.
The network statistical analyses were performed using the
MorphoConnect toolbox (Melie-García et al., 2010), while global CBF
data was analyzed using STATISTICA software (Stat Soft, Inc., version
8.0). The signiﬁcance level was set at p < 0.05.
3. Results
The administration of ACZ was well tolerated in all individuals.
There were no signiﬁcant diﬀerences between conditions (basal vs.
ACZ) in both groups in heart rate (Control: 68.2 ± 9.9 vs.
67.2 ± 9.4 bpm, respectively, p = 0.6, paired t-test; MCI:
70.4 ± 9.4 vs. 67.4 ± 7.1 bpm, respectively, p = 0.09) and mean
arterial pressure (Control: 106.9 ± 10.8 vs. 106.5 ± 9.9 mm Hg,
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respectively, p = 0.8; MCI: 102. 8 ± 10.9 vs. 105.9 ± 10.8 mm Hg,
respectively, p = 0.1).
3.1. Changes in standard metrics
At the global level, there was a signiﬁcant increase in gCBFACZ as
compared with gCBFBasal in both groups (Control: 42.0 ± 5.5 vs.
54.9 ± 6.3 mL/min/100 g; p < 10−6; MCI: 38.9 ± 6.7 vs.
51.1 ± 7.3 mL/min/100 g; p < 10−6) (Supplementary Fig. S1). The
percent of the increase in the control group (+31.4 ± 9.2) was
comparable to that found in the MCI group (+32.7 ± 12.9). There
were no signiﬁcant diﬀerences between groups in the basal (p = 0.21)
and ACZ conditions (p = 0.07). No signiﬁcant interaction of group and
condition was found (p = 0.75).
At the voxel level, the analysis of diﬀerences between condition
within-group showed a similar pattern in the control and MCI groups.
Both groups showed signiﬁcant regional CBF increases mainly in frontal
regions bilaterally, after removal of the eﬀect of global CBF increase
due to ACZ (Fig. 2.A and B, Supplementary Table S2). In the control
group, the voxel with the lowest p-value was found in the right superior
frontal gyrus (medial part) (MNI: x, y, z = 15, 56, 31; PFWE = 10−3,
T = 6.21). In the MCI group, the right superior frontal gyrus (dorso-
lateral part) was the voxel with the lowest p-value (MNI: x, y, z = 15,
35, 55; PFWE = 10−3, T = 6.18). Neither group showed a signiﬁcant
regional decrease.
On the other hand, the group diﬀerence within-condition showed a
regional CBF decrease in the MCI group as compared to the control
group in the basal condition, mostly in temporoparietal regions
bilaterally (Fig. 2.C, Supplementary Table S3). In the right angular
gyrus was the voxel with the lowest p-value (MNI: x, y, z = 45, −70,
34; PFWE = 0.05, T = 4.52). At the ACZ condition, the results were
relatively similar to those observed in basal condition, although less
extensive and the right temporoparietal region showed no diﬀerence as
compared to the control group (Fig. 2.D, Supplementary Table S3). In
Fig. 2. CBF changes at the voxel level analyzed by a 2 (group: Control and MCI) × 2 (condition: basal and ACZ) full factorial design using statistical parametric mapping (SPM). Figures A
and B show that the control and MCI groups had a similar regional pattern of CBF increase in frontal lobe bilaterally. Figures C and D show that the regional diﬀerences between groups
were relatively similar in the two conditions, although less extensive in the ACZ condition. No interaction of the group by the condition was found.
SPM t-maps are visualized onto the cortical surfaces using the BrainNet Viewer package (http://www.nitrc.org/projects/bnv).
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the left angular gyrus was the voxel with the lowest p-value (MNI: x, y,
z =−45, 61, 37; PFWE = 0.004, T = 5.17). In the basal and ACZ
conditions in the MCI group, as compared to the control group, also no
signiﬁcant regional CBF increases were found. No signiﬁcant interac-
tion of group and condition were observed neither positive nor
negative.
3.2. Changes in network metrics
At the global level, the control group showed no signiﬁcant changes
of Cglobal and SAglobal (no changes of CBF co-variation) in response to the
ACZ challenge. In contrast to the control, the MCI group showed a
decrease in Cgloblal and SAglobal (Fig. 3 and Table 2; see also Supplemen-
tary Fig. S2).
Moreover, SAglobal was higher in the MCI group as compared to the
control in the basal condition (Fig. 3 and Table 2). Although not
signiﬁcant, a similar diﬀerence for Cgloblal in the MCI group was found
(Fig. 3 and Supplementary Fig. S2). At the ACZ condition, no signiﬁcant
diﬀerences were observed for Cglobal and SAglobal between the MCI and
control groups (Fig. 3 and Table 2; see also Supplementary Fig. S2).
However, unlike the standard analysis, we found a signiﬁcant crossover
interaction eﬀect of group and condition for SAglobal (Table 2). Thus,
compared to the control group, the MCI group showed a speciﬁc
decrease in SAglobal induced by the ACZ challenge. For Cglobal, a similar
interaction was observed although did not reach signiﬁcance (Supple-
mentary Fig. S2).
At the nodal level, the control group showed no signiﬁcant change
in Cnodal in response to ACZ after multiple comparisons correction (4.A
and 4.B); while SAnodal showed an increase in the right inferior temporal
gyrus (Fig. 4.C) and decreases in the frontal superior and middle
temporal pole on the left side (Fig. 4.D). In contrast to the control, the
MCI group showed decreases in Cnodal in the hippocampus and the
fusiform gyrus on the right side and in the dorsal medial prefrontal
cortex on the left side (Fig. 4.E and F). In this group, SAnodal increased in
the postcentral gyrus (Fig. 4.G) and decreased in the superior frontal,
middle frontal, lingual and fusiform gyri on the right side, and in the
left middle occipital gyrus (Fig. 4.H).
On the other hand, the group diﬀerence within-conditions showed
that in the MCI group, in the basal condition, Cnodal was increased in the
inferior parietal lobe bilaterally and in lingual and fusiform gyri on the
right side (Fig. 5.A and B); whereas SAnodal was increased in the lingual
gyrus bilaterally and in the right inferior temporal and left middle
occipital gyri (Fig. 5.C and D). At the ACZ condition, both groups
showed no signiﬁcant changes in both Cnodal and SAnodal (Fig. 5.E–H).
However, similar to global network metrics, there was a signiﬁcant
crossover interaction eﬀect of group and condition for both Cnodal and
SAnodal (Fig. 6). Compared to the control group, the MCI group showed
a speciﬁc decrease in Cnodal induced by the ACZ in the lingual, fusiform
and superior temporal gyri on the right side after multiple comparisons
correction (Fig. 6.A); and a speciﬁc decrease in SAnodal in the middle
frontal region and in the lingual, fusiform and inferior temporal gyri on
the right side and in the left thalamus (Fig. 6.C).
When the interaction eﬀects described above were examined less
conservatively (uncorrected statistic), we found that the MCI group
showed a speciﬁc decrease in Cnodal mainly in regions comprising the
inferior parietal lobe and medial prefrontal cortex bilaterally, the
parahippocampal gyrus and the lateral temporal cortex on the right
side (Fig. 6.E and F). Both thalamus also showed a decrease in Cnodal.
Moreover, a speciﬁc increase in Cnodal was found mainly in frontal and
occipital regions on the right side, and in the anterior and posterior
cingulate on the left side. Likewise, SAnodal showed concurrent changes
in Cnodal (increase or decrease) in several regions as shown in the
Fig. 6.E–H. An opposite change in Cnodal and SAnodal was also observed
in the right middle frontal region (Fig. 6.E and G).
3.3. Supplementary morphometric analysis
Regional GMV was decreased signiﬁcantly in the lateral and medial
temporal regions (including hippocampi) in the MCI group compared
with the control group (Supplementary Fig. S3 and Supplementary
Table S4). In contrast to GMV, no signiﬁcant diﬀerences were observed
between groups in WMV.
4. Discussion
This study investigated ACZ-induced changes in the topology of the
CBFcorr networks in normal cognition and MCI subjects. We found that
normal cognition and MCI show diﬀerent patterns of C and SA changes,
Fig. 3. Global clustering coeﬃcient (Cgloblal) and mean strength of association (SAglobal) in the control and MCI groups in the two condition: basal and under the ACZ challenge. The data
were generated by bootstrapping the CBF correlation matrices (1000 samples per group and condition). Comparisons were performed by estimating 95% bootstrap conﬁdent intervals
(see main text for details). *Signiﬁcant eﬀect.
Table 2
Simple main eﬀects and interactions of group and condition at the global level.
Eﬀect Mean (95% CI) - Cglobal Mean (95% CI) - SAglobal
ACZ vs. basal
(Control)
0.12 (−0.90 – +0.63) 0.00004 (−0.02 – +0.009)
ACZ vs. basal (MCI) −0.68 (−1.44 –−0.97)a −0.026 (−0.04 –−0.01)a
Control vs. MCI
(basal)
−0.56 (−1.28 – +0.16) −0.019 (−0.03 –−0.003)a
Control vs. MCI
(ACZ)
0.24 (−0.61 – +0.84) 0.007 (−0.02 – +0.02)
Interaction 0.79 (−0.14 – +1.75) 0.03 (+0.0006 – +0.04)a
ACZ, acetazolamide; CI, conﬁdent interval.
a Signiﬁcant eﬀect.
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while the standard approach did not detect substantial diﬀerences.
Thus, our ﬁndings support the concept that multivariate measures (i.e.
co-variations) combined with a graph theoretical approach are more
sensitive to identify complex pathological processes, as has found in
other brain diseases (Bassett et al., 2012; He et al., 2009b). Univariate
measures derived from the standard approach could be insuﬃcient for
capturing subtle (early) abnormal changes.
4.1. CBF imaging under the ACZ challenge
The global CBF increase in both groups veriﬁes the reliability of the
methodology used for CBF imaging under the ACZ challenge. The
percent of the increase in the two groups was comparable to previous
studies in healthy subjects using a similar methodology (Boles Ponto
et al., 2004, for a review).
An interesting observation is the highest regional CBF increase in
response to ACZ in frontal cortices in both groups (Fig. 2.A and B). As
far as we know, this has not been previously reported. The highest
frontal CBF is possibly caused by greater oxygen metabolism in these
regions before ACZ administration. This explanation is substantiated by
the fact that the neuronal activity is high in frontal regions during the
resting state (Ingvar, 1979) and there is a direct relationship between
the CBF response to the ACZ and pre-existing oxygen metabolic activity
(Yamauchi et al., 2002).
Moreover, the basal temporoparietal CBF reduction observed in the
MCI group as compared to the control group (Fig. 2.C) is the typical AD-
like hypoperfusion pattern previously described (Herholz et al., 2002).
The group diﬀerence in the ACZ condition was also relatively similar to
those observed in the basal condition. Thus, the basal regional CBF
reduction in the MCI group was not misery perfusion since microvessels
responded to the ACZ. The basal hypoperfusion is likely mainly related
to a reduced level of regional metabolic activity (Herholz et al., 2002).
4.2. Patterns of ACZ-induced changes in CBF correlation networks
The control (cognitively normal) group network showed only a little
or almost no topological changes in response to the ACZ challenge
(Figs. 3 and 4.A–D). That is, the control group network seems to have
the capability to adapt to the challenge. Possibly, this reﬂects the
process to maintain the brain microenvironment homeostasis (Iadecola,
2004), vital for brain function, in response to the vascular challenge
induced by the ACZ (Vagal et al., 2009). In contrast, the MCI group
network showed a decrease in C and SA, especially at the global level
(Fig. 3), suggesting that the above process is possibly altered to some
extent in the MCI stage not detected by the standard analysis. On the
other hand, although speculative, the SAglobal increase in the MCI group
network in the basal condition might represent an adaptive mechanism
in response to the eﬀects of the pathological process.
Perhaps, the most revealing ﬁnding is the crossover interaction
eﬀect between group and condition, in particular, when analyzed in a
less conservative way (Fig. 6.E–H). For example, the patterns of Cnodal
and SAnodal decreases (mainly Cnodal, the bottom of Fig. 6.E and F)
partially correspond with the regional CBF reduction in the MCI group
in the basal condition (Fig. 2.C). The overlap increases if the atrophy
found in the MCI group is included (Supplementary Fig. S3), which
suggests that these functional and structural abnormalities could be
related to the ACZ-induced changes observed in the MCI group network
since they are both biomarkers of neuronal injury of MCI due to AD
Fig. 4. Signiﬁcant diﬀerences between condition within-group at the nodal level for the clustering coeﬃcient (Cnodal) and mean strength of association (SAnodal) in the control (A–D) and
MCI groups (E–H).
Regional changes are mapped onto the cortical surfaces using the BrainNet Viewer package (http://www.nitrc.org/projects/bnv).
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(Sánchez-Catasús et al., 2017, for a review).
Interestingly, the patterns of Cnodal decrease (the bottom of Fig. 6.E
and F) also overlap to a certain extent with the default mode network
(DMN), which is very active in the resting state (Hafkemeijer et al.,
2012, for a review). Thus, it is plausible that these patterns could be
related to altered changes in the topology of the DMN's vascular
component, considering that the CBFcorr network was studied in two
resting states: pre-ACZ and under the eﬀect of the ACZ. It is known that
DMN also overlaps the brain network underlying the episodic memory
(Rugg and Vilberg, 2013) that is speciﬁcally aﬀected in MCI due to AD
(Albert et al., 2011).
Furthermore, the DMN regions are also targets of the AD process
(Ingelsson et al., 2004; Villain et al., 2012), which may disrupt CBF co-
variation in response to the vasodilatory challenge. The available
evidence suggests that various pathological mechanisms of AD may
contribute to alterations of CVR as a result of damage to the
cerebrovascular system (Glodzik et al., 2013, for a review). Never-
theless, such mechanisms could have less expression in the MCI stage,
especially in patients with a low vascular load. Consequently, subtle
CVR alterations would be diﬃcult to detect by the standard approach,
in agreement with previous studies with negative ﬁndings (Shim et al.,
2015; Fromm et al., 2013; Anzola et al., 2011).
Moreover, the Cnodal increase in the MCI group network in the basal
condition (the top of Fig. 5.A and B) also showed a partial correspon-
dence with the Cnodal decrease induced by the ACZ (the bottom of
Fig. 6.E and F). This overlap implies that in these regions Cnodal is
changing from a high basal to a low ACZ value, thus being the regions
with the greatest negative changes. Notably, these regions include the
inferior parietal lobe bilaterally which also overlap with the regional
CBF reduction in the MCI group in the basal condition (Fig. 3.C).
Of interest is also the opposite change of Cnodal (increase) and SAnodal
(decrease) in the right middle frontal region (the top of the Fig. 6.E and
the bottom of the Fig. 6.G, respectively), which partially corresponds
with the regional CBF increase in the MCI group (Fig. 2.B).
As a ﬁnal point, let us consider some issues regarding our study
population of MCI patients. The criteria for patient selection and the
episodic memory reduction in the MCI group (Supplementary Table S1)
indicate that our patients presented amnestic MCI. Furthermore,
hippocampal atrophy in the MCI group (Supplementary Fig. S3 and
Supplementary Table S4) suggests that most of our patients could
evolve to AD dementia, with an intermediate level of certainty
according to the latest diagnostic criteria for MCI due to AD (Albert
et al., 2011). Still, we cannot exclude the possibility that some of our
MCI patients evolve to another type of degenerative dementia as MCI is
a complex heterogeneous condition.
4.3. Study limitations
First, some results at the nodal level and their interpretations should
be taken with caution since they are based on an uncorrected statistic.
Yet, these ﬁndings are meaningful given the partial correspondence
found with the other results in this study using a corrected statistic. In
order to increase the eﬀect size at the nodal level, it may be necessary to
increase the number of subjects and/or to use a more potent vasodilator
stimulus in future studies. Second, our results are only valid at the
group level. However, the present study is a necessary ﬁrst step for a
further study based on individual level. A recent study demonstrated
that it is possible to estimate the individual contribution of a single
subject to group-based correlation networks and to examine its
association with clinical data (Saggar et al., 2015). A third limitation
Fig. 5. Signiﬁcant diﬀerences between group within-condition at the nodal level for the clustering coeﬃcient (Cnodal) and mean strength of association (SAnodal) in the basal (A–D) and
ACZ conditions (E–H).
Regional changes are mapped onto the cortical surfaces using the BrainNet Viewer package (http://www.nitrc.org/projects/bnv).
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is that this is a cross-sectional study, whereas longitudinal studies are
needed to clarify the temporal evolution of the CBFcorr network along
the continuum from normal aging to AD dementia. Four, graph
theoretical analysis of the CBFcorr network has limitations that were
discussed in our previous article (e.g. the use of Pearson's correlation
instead of partial correlation; choice of parcellation scheme; possible
variability of results with diﬀerent sample sizes) (Melie-García et al.,
2013). In addition, a recent study showed that the inclusion of global
CBF as a confounding variable introduces artiﬁcial negative correla-
tions in networks using resting state fMRI data (Carbonell et al., 2014),
which might also be present in correlation networks using CBF SPECT.
Nevertheless, all of these limitations are attenuated to some extent by
studying the CBFcorr network in two diﬀerent conditions, i.e. by
analyzing the vasodilatory eﬀect of ACZ after subtracting the eﬀect of
baseline. The vasodilatory eﬀect of ACZ could be considered compara-
tively greater than the eﬀects of the above methodological short-
comings.
4.4. Conclusions
This study suggests that graph theoretical analysis of ACZ-induced
changes in the topology of the CBFcorr networks can detect subtle
network-related CVR alterations in MCI not reﬂected by the standard
approach. These alterations involve brain regions directly related to
cognitive dysfunction in MCI. Our results also warrant further research
on the individual level to develop a ‘network’-based CVR biomarker of
MCI due to AD.
Acknowledgements
The authors thank the collaboration of Drs. Yasser Iturria-Medina,
Luis Juárez Orozco, Yurelis Ginarte and Fransje Reesink for their
invaluable helps. The authors also thank the support of the Center for
Neurological Restoration (CIREN), Havana, Cuba, and Department of
Nuclear Medicine and Molecular Imaging, University Medical Center
Groningen, the Netherlands.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2017.04.019.
References
Achard, S., Bullmore, E., 2007. Eﬃciency and cost of economical brain functional
networks. PLoS Comput. Biol. 3 (2), e17.
Achard, S., Salvador, R., Whitcher, B., Suckling, J., Bullmore, E., 2006. A resilient, low
frequency, small-world human brain functional network with highly connected
association cortical hubs. J. Neurosci. 26 (1), 63–72.
Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A.,
Holtzman, D.M., Jagust, W.J., Petersen, R.C., Snyder, P.J., Carrillo, M.C., Thies, B.,
Phelps, C.H., 2011. The diagnosis of mild cognitive impairment due to Alzheimer's
disease: recommendations from the National Institute on Aging-Alzheimer's
Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers
Dement. 7 (3), 270–279.
Alexander-Bloch, A., Giedd, J.N., Bullmore, E., 2013. Imaging structural co-variance
between human brain regions. Nat. Rev. Neurosci. 14 (5), 322–336.
Anzola, G.P., Galluzzi, S., Mazzucco, S., Frisoni, G.B., 2011. Autonomic dysfunction in
mild cognitive impairment: a transcranial Doppler study. Acta Neurol. Scand. 124
(6), 403–409.
Bassett, D.S., Nelson, B.G., Mueller, B.A., Camchong, J., Lim, K.O., 2012. Altered resting
state complexity in schizophrenia. NeuroImage 59 (3), 2196–2207.
Fig. 6. Signiﬁcant crossover interaction eﬀects of group and condition at the nodal level for the clustering coeﬃcient (Cnodal) and mean strength of association (SAnodal) with Bonferroni
correction (A–D) and without correction (E–H).
Regional changes are mapped onto the cortical surfaces using the BrainNet Viewer package (http://www.nitrc.org/projects/bnv).
C.A. Sánchez-Catasús et al. NeuroImage: Clinical 15 (2017) 151–160
159
Boles Ponto, L.L., Schultz, S.K., Watkins, G.L., Hichwa, R.D., 2004. Technical issues in the
determination of cerebrovascular reserve in elderly subjects using 15O-water PET
imaging. NeuroImage 21 (1), 201–210.
Bullmore, E.T., Bassett, D.S., 2011. Brain graphs: graphical models of the human brain
connectome. Annu. Rev. Clin. Psychol. 7, 113–140.
Cantin, S., Villien, M., Moreaud, O., Tropres, I., Keignart, S., Chipon, E., Le Bas, J.F.,
Warnking, J., Krainik, A., 2011. Impaired cerebral vasoreactivity to CO2 in
Alzheimer's disease using BOLD fMRI. NeuroImage 58 (2), 579–587.
Carbonell, F., Bellec, P., Shmuel, A., 2014. Quantiﬁcation of the impact of a confounding
variable on functional connectivity conﬁrms anti-correlated networks in the resting-
state. NeuroImage 86, 343–353.
Fromm, A., Lundervold, A.J., Moen, G., Skulstad, S., Thomassen, L., 2013. A vascular
approach to mild amnestic cognitive impairment: a pilot study. Acta Neurol. Scand.
Suppl. 196, 73–76.
Glodzik, L., Rusinek, H., Brys, M., Tsui, W.H., Switalski, R., Mosconi, L., Mistur, R.,
Pirraglia, E., de Santi, S., Li, Y., Goldowsky, A., de Leon, M.J., 2011. Framingham
cardiovascular risk proﬁle correlates with impaired hippocampal and cortical
vasoreactivity to hypercapnia. J. Cereb. Blood Flow Metab. 31 (2), 671–679.
Glodzik, L., Randall, C., Rusinek, H., deLeon, M.J., 2013. Cerebrovascular reactivity to
carbon dioxide in Alzheimer's disease. J. Alzheimers Dis. 35 (3), 427–440.
Hafkemeijer, A., van der Grond, J., Rombouts, S.A., 2012. Imaging the default mode
network in aging and dementia. Biochim. Biophys. Acta 1822 (3), 431–441.
Hamilton, M., 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23,
56–62.
He, Y., Chen, Z.J., Evans, A.C., 2007. Small-world anatomical networks in the human
brain revealed by cortical thickness from MRI. Cereb. Cortex 17 (10), 2407–2419.
He, Y., Chen, Z., Gong, G., Evans, A., 2009a. Neuronal networks in Alzheimer's disease.
Neuroscientist 15 (4), 333–550.
He, Y., Dagher, A., Chen, Z., Charil, A., Zijdenbos, A., Worsley, K., Evans, A., 2009b.
Impaired small-world eﬃciency in structural cortical networks in multiple sclerosis
associated with white matter lesion load. Brain 132 (Pt 12), 3366–3379.
Herholz, K., Schopphoﬀ, H., Schmidt, M., Mielke, R., Eschner, W., Scheidhauer, K., et al.,
2002. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's
disease. J. Nucl. Med. 43, 21–26.
Iadecola, C., 2004. Neurovascular regulation in the normal brain and in Alzheimer's
disease. Nat. Rev. Neurosci. 5 (5), 347–360.
Ingelsson, M., Fukumoto, H., Newell, K.L., Growdon, J.H., Hedley-Whyte, E.T., Frosch,
M.P., Albert, M.S., Hyman, B.T., Irizarry, M.C., 2004. Early Abeta accumulation and
progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62 (6),
925–931.
Ingvar, D.H., 1979. “Hyperfrontal” distribution of the cerebral grey matter ﬂow in resting
wakefulness; on the functional anatomy of the conscious state. Acta Neurol. Scand. 60
(1), 12–25.
Iturria-Medina, Y., Sotero, R.C., Canales-Rodríguez, E.J., Alemán-Gómez, Y., Melie-
García, L., 2008. Studying the human brain anatomical network via diﬀusion-
weighted MRI and Graph Theory. NeuroImage 40 (3), 1064–1076.
Lassen, N.A., Andersen, A.R., Friberg, L., Paulson, O.B., 1988. The retention of [99mTc]-
d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.
J. Cereb. Blood Flow Metab. 8 (6), S13–S22.
Melie-García, L., Sanabria-Diaz, G., Iturria-Medina, Y., Alemán-Gómez, Y., 2010.
MorphoConnect: toolbox for studying structural brain networks using morphometric
descriptors. In: 16th Annual Meeting of the Organization for Human Brain Mapping,
(Barcelona, Spain).
Melie-García, L., Sanabria-Diaz, G., Sánchez-Catasús, C., 2013. Studying the topological
organization of the cerebral blood ﬂow ﬂuctuations in resting state. NeuroImage 64,
173–184.
Morris, J.C., 1993. The clinical dementia rating (CDR): current version and scoring rules.
Neurology 43 (11), 2412–2414.
Pillai, J.J., Mikulis, D.J., 2015. Cerebrovascular reactivity mapping: an evolving standard
for clinical functional imaging. AJNR Am. J. Neuroradiol. 36 (1), 7–13.
Richiardi, J., Monsch, A.U., Haas, T., Barkhof, F., Van de Ville, D., Radü, E.W., Kressig,
R.W., Haller, S., 2014. Altered cerebrovascular reactivity velocity in mild cognitive
impairment and Alzheimer's disease. Neurobiol. Aging 36 (1), 33–41.
Rugg, M.D., Vilberg, K.L., 2013. Brain networks underlying episodic memory retrieval.
Curr. Opin. Neurobiol. 23 (2), 255–260.
Saggar, M., Hosseini, S.M., Bruno, J.L., Quintin, E.M., Raman, M.M., Kesler, S.R., Reiss,
A.L., 2015. Estimating individual contribution from group-based structural
correlation networks. NeuroImage 120, 274–284.
Sanabria-Diaz, G., Martinez-Montes, E., Melie-Garcia, L., 2013. Glucose metabolism
during resting state reveals abnormal brain networks organization in the Alzheimer's
disease and mild cognitive impairment. PLoS ONE 8 (7), e68860.
Sánchez-Catasús, C.A., Stormezand, G.N., van Laar, P.J., De Deyn, P.P., Sánchez, M.A.,
Dierckx, R.A., 2017. FDG-PET for prediction of AD dementia in mild cognitive
impairment. A review of the state of the art with particular emphasis on the
comparison with other neuroimaging modalities (MRI and perfusion SPECT). Curr.
Alzheimer Res. 14, 127–142.
Shim, Y., Yoon, B., Shim, D.S., Kim, W., An, J.Y., Yang, D.W., 2015. Cognitive correlates
of cerebral vasoreactivity on transcranial Doppler in older adults. J. Stroke
Cerebrovasc. Dis. 24 (6), 1262–1269.
Takasawa, M., Murase, K., Oku, N., Yoshikawa, T., Osaki, Y., Imaizumi, M., Matsuzawa,
H., Fujino, K., Hashikawa, K., Kitagawa, K., Hori, M., Matsumoto, M., 2002.
Assessment of acetazolamide reactivity in cerebral blood ﬂow using spectral analysis
and technetium-99m hexamethylpropylene amine oxime. J. Cereb. Blood Flow
Metab. 22 (8), 1004–1009.
Tijms, B.M., Wink, A.M., de Haan, W., van der Flier, W.M., Stam, C.J., Scheltens, P.,
Barkhof, F., 2013. Alzheimer's disease: connecting ﬁndings from graph theoretic
studies of brain networks. Neuorobiol. Aging 34 (8), 2023–2036.
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N.,
Mazoyer, B., Joliot, M., 2002. Automated anatomical labeling of activations in SPM
using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
NeuroImage 15 (1), 273–289.
Vagal, A.S., Leach, J.L., Fernandez-Ulloa, M., Zuccarello, M., 2009. The acetazolamide
challenge: techniques and applications in the evaluation of chronic cerebral ischemia.
AJNR Am. J. Neuroradiol. 30 (5), 876–884.
Van Laere, K.J., Versijpt, J., Koole, M., Vandenberghe, S., Lahorte, P., Lemahieu, I.,
Dierckx, R.A., 2002. Experimental performance assessment of SPM for SPECT
neuroactivation studies using a subresolution sandwich phantom design. NeuroImage
16 (1), 200–216.
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K.A., Ames, D., Martins,
R.N., Eustache, F., Salvado, O., Masters, C.L., Rowe, C.C., Villemagne, V.L., AIBL
Research Group, 2012. Regional dynamics of amyloid-β deposition in healthy elderly,
mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal
study. Brain 135 (Pt 7), 2126–2139.
Watts, D.J., Strogatz, S.H., 1998. Collective dynamics of ‘small-world’ networks. Nature
393, 440–442.
Wu, K., Taki, Y., Sato, K., Kinomura, S., Goto, R., Okada, K., Kawashima, R., He, Y., Evans,
A.C., Fukuda, H., 2012. Age-related changes in topological organization of structural
brain networks in healthy individuals. Hum. Brain Mapp. 33 (3), 552–568.
Yamauchi, H., Okazawa, H., Kishibe, Y., Sugimoto, K., Takahashi, M., 2002. Reduced
blood ﬂow response to acetazolamide reﬂects pre-existing vasodilation and decreased
oxygen metabolism in major cerebral arterial occlusive disease. Eur. J. Nucl. Med.
Mol. Imaging 29 (10), 1349–1356.
Zavoreo, I., Kes, V.B., Morovic, S., Seric, V., Demarin, V., 2010. Breath holding index in
detection of early cognitive decline. J. Neurol. Sci. 299 (1–2), 116–119.
C.A. Sánchez-Catasús et al. NeuroImage: Clinical 15 (2017) 151–160
160
